MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Smartwatch-Based Screening to Identify Candidates for Deep Brain Stimulation in Parkinson’s Disease

    R. Fadil, B. Walter, G. Kuhlman, S. Zaidi, D. Heldman (Cleveland, USA)

    Objective: To use smartwatches to identify candidates for deep brain stimulation (DBS). Background: DBS can meaningfully lessen Parkinson's disease (PD) motor symptoms and improve quality…
  • 2024 International Congress

    Acceptability of Digital Health Technologies in Early Parkinson’s Disease

    T. Kangarloo, R. Latzman, J. Adams, E. Dorsey, M. Kostrzebski, D. Anderson, F. Horak, D. Stephenson, J. Cosman (Cambridge, USA)

    Objective: The Wearable Assessments in the Clinic and at Home in PD (WATCH-PD) study is an observational, longitudinal study in early PD looking at disease…
  • 2024 International Congress

    Optimal measuring height and validation of 2D-LiDAR based analysis system for spatiotemporal gait parameters

    S. Woo, C. Shin, MY. Kim (Daegu, Republic of Korea)

    Objective: This study aims to validate a 2D light detection and ranging (LiDAR) based gait analysis system with a reference system. In addition, the optimal…
  • 2024 International Congress

    eHealth – an Opportunity for personalized Care? – Healthcare Professionals’ Technology Acceptance in the Care of Parkinson’s Patients

    J. Stuempel, J. Hohn, V. Fleckenstein, K. Steidel, C. Münte, D. Pedrosa (Marburg, Germany)

    Objective: To examine how eHealth may improve personalized care for people with Parkinson's disease (PwPD) from the perspective of healthcare professionals (HCPs). Background: Parkinson's disease…
  • 2024 International Congress

    How does the PPP2R2B mutation alter neuronal cytoskeletal structure in SCA12

    A. Ganguly, B. Reddy, J. Rungta, S. Choudhury, R. Pal, H. Kumar, S. Chattarji (Kolkata, India)

    Objective: To study the effect of the PPP2R2B mutation on human induced pluripotent stem cell (iPSC) derived neurons in SCA12 patients. Background: SCA12 is an…
  • 2024 International Congress

    Pulmonary Dysfunction in Friedreich’s Ataxia (FRDA)

    T. Zesiewicz, T. Vu, A. Patel, T. Mcdonald, Y. Huang, Y. Zhao, L. Campbell, L. Evans, D. Mohan, C. Gooch, K. Calero (Tampa, USA)

    Objective: We sought to characterize pulmonary function in FRDA and identify disease variables that may contribute to dysfunction. Background: FRDA is a neurodegenerative disease that causes…
  • 2024 International Congress

    Substantia Nigra Degeneration In Spinocerebellar Ataxia 2 And 7 Using Neuromelanin-Sensitive Imaging

    L. Chougar, G. Coarelli, FX. Lejeune, R. Gaurav, P. Ziegner, A. Durr, S. Lehéricy (PARIS, France)

    Objective: To assess substantia nigra pars compacta (SN) degeneration in SCA type 2 and 7 using neuromelanin-sensitive MRI Background: Spinocerebellar ataxias (SCA) are often associated…
  • 2024 International Congress

    Clinico-radiological and genetic profile of patients with Ataxia with Oculomotor apraxia type-2 (AOA2)- A case series from India

    M. Chandarana, B. Tilva, A. Agarwal, D. Garg (Ahmedabad, India)

    Objective: To delineate clinical, radiological and genetic profile of patients with ataxia with oculomotor apraxia type-2 (AOA2) in Indian cohort. Background: AOA2 is a relatively…
  • 2024 International Congress

    A study on the phenomenological analysis of Spinocerebellar Ataxia type 12 revealing a dystonic imprint

    A. Mukherjee, S. Pandey (Faridabad, India)

    Objective: To assess the presence and distribution of dystonia in spinocerebellar ataxia type 12 (SCA12). Background: SCA12, commonly seen in the Agarwal community in India,…
  • 2024 International Congress

    Chorea Acanthocytosis Misdiagnosed as Functional Movement Disorder

    A. Crutchfield, N. Reddy, A. Ahmed, M. Lotia (Orlando, USA)

    Objective: To highlight the importance of genetic testing when the clinical symptoms of Chorea Acanthocytosis (ChAc) are misdiagnosed as functional movement disorder (FMD). Background: ChAc…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 181
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley